Detalhe da pesquisa
1.
Experience with Tofacitinib in Patients with Ulcerative Colitis: Data from a United States Claims Database.
Dig Dis Sci
; 68(10): 3985-3993, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37639057
2.
Predictors of nonresponse to dupilumab in patients with atopic dermatitis: A machine learning analysis.
Ann Allergy Asthma Immunol
; 129(3): 354-359.e5, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35640774
3.
Retrospective Database Analysis: Dose Escalation and Adherence in Patients Initiating Biologics for Ulcerative Colitis.
Dig Dis
; 40(5): 553-564, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34879378
4.
Experience with tofacitinib in Canada: patient characteristics and treatment patterns in rheumatoid arthritis over 3 years.
Rheumatology (Oxford)
; 59(3): 568-574, 2020 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31410469
5.
Tofacitinib in combination with methotrexate in patients with rheumatoid arthritis: patient-reported outcomes from the 24-month Phase 3 ORAL Scan study.
Clin Exp Rheumatol
; 38(5): 848-857, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31858963
6.
Tofacitinib versus methotrexate in rheumatoid arthritis.
N Engl J Med
; 370(25): 2377-86, 2014 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-24941177
7.
Tofacitinib or adalimumab versus placebo: patient-reported outcomes from a phase 3 study of active rheumatoid arthritis.
Rheumatology (Oxford)
; 55(6): 1031-41, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26929445
8.
Effects of the oral Janus kinase inhibitor tofacitinib on patient-reported outcomes in patients with active rheumatoid arthritis: results of two Phase 2 randomised controlled trials.
Clin Exp Rheumatol
; 34(3): 430-42, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27156561
9.
Placebo-controlled trial of tofacitinib monotherapy in rheumatoid arthritis.
N Engl J Med
; 367(6): 495-507, 2012 Aug 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-22873530
10.
Tofacitinib or adalimumab versus placebo in rheumatoid arthritis.
N Engl J Med
; 367(6): 508-19, 2012 Aug 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-22873531
11.
Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial.
Lancet
; 381(9865): 451-60, 2013 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-23294500
12.
Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: twelve-month data from a twenty-four-month phase III randomized radiographic study.
Arthritis Rheum
; 65(3): 559-70, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23348607
13.
Tofacitinib in combination with nonbiologic disease-modifying antirheumatic drugs in patients with active rheumatoid arthritis: a randomized trial.
Ann Intern Med
; 159(4): 253-61, 2013 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-24026258
14.
Tofacitinib Efficacy in Patients with Rheumatoid Arthritis and Probable Depression/Anxiety: Post Hoc Analysis of Phase 3 and 3b/4 Randomized Controlled Trials.
Rheumatol Ther
; 11(1): 35-50, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37925660
15.
A phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) versus placebo in combination with background methotrexate in patients with active rheumatoid arthritis and an inadequate response to methotrexate alone.
Arthritis Rheum
; 64(4): 970-81, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22006202
16.
Phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) or adalimumab monotherapy versus placebo in patients with active rheumatoid arthritis with an inadequate response to disease-modifying antirheumatic drugs.
Arthritis Rheum
; 64(3): 617-29, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21952978
17.
High Usability and Applicability Ratings for the New SmartClic®/ClicWise® Injection Device: Evidence from a Health Care Professional Opinion Study.
Rheumatol Ther
; 10(2): 477-487, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36689125
18.
Effectiveness and Safety of Tofacitinib in Canadian Patients With Rheumatoid Arthritis: Primary Results From a Prospective Observational Study.
Arthritis Care Res (Hoboken)
; 75(2): 240-251, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35678771
19.
Sex differences in the efficacy, safety and persistence of patients with psoriatic arthritis treated with tofacitinib: a post-hoc analysis of phase 3 trials and long-term extension.
RMD Open
; 9(1)2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36958766
20.
Early Real-World Experience of Tofacitinib for Psoriatic Arthritis: Data from a United States Healthcare Claims Database.
Adv Ther
; 39(6): 2932-2945, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35482248